Learn more about Coyote Ventures' thesis: investing in tech-enabled solutions that drive access to healthcare for overlooked populations.

Diving into our Health Equity Thesis

We launched Coyote Ventures in 2021 with the belief that investing in companies designed to optimize the health of traditionally overlooked populations, especially women, provides both a powerful opportunity for impact and strong potential for high returns. Years later, we are proud to have backed a variety of companies advancing health equity, improving the lives of women and other historically marginalized communities. Our portfolio spans traditional women’s health, addressing conditions like endometriosis, breast cancer, and maternal health, as well as broader health equity challenges such as social barriers to care, family building resources, aging, caregiving, and much more.

Portfolio highlights:

Helps people afford family planning, starting with a financing plan for IVF.

Combines a digital platform with clinical support to help patients create actionable directives, ensuring their wishes are clearly understood by their healthcare practitioners.

Helps healthcare systems proactively identify barriers to care and helps to close the loop on resource referrals.

Delivers doula-led care to support women through pregnancy and postpartum, with a focus on high-risk pregnancies and birth equity. 

Clinically integrated approach transforms the experience of caring for an adult living with a chronic condition.

Insurance-based paid parental leave programs support working parents with a personalized employee experience and help reduce the financial burden on small businesses.

Our 2024 Impact Report shows how we embed a health equity framework into our investment strategy. We invest in tech-enabled solutions that drive access to healthcare for overlooked populations, and we examine intersecting inequities such as gender, race, socioeconomic status, cultural considerations, and literacy. Many issues affecting women are amplified for women of color; for example, maternal mortality in the US is 3.5x higher for Black women than white women.

Women have long been overlooked and marginalized—a reality starkly reflected in health disparities.

On average, women spend 25% more of their lives in poor health than men. Women’s health spans biological, hormonal, and genetic differences, as well as gender-specific experiences. This includes reproductive health issues like menstruation, pregnancy, and menopause, alongside diseases such as breast and ovarian cancer. Conditions like osteoporosis and autoimmune diseases disproportionately impact women, and others, such as heart disease, may present differently than in men. Addressing women’s health requires specialized care that accounts not only for these biological differences but also for the societal barriers that limit women’s access to care. While our investments focus on categories that affect women in unique ways, we’ve structured our impact framework in a novel way that directly aligns with improving the health of women.

Rapid advances in technology, including AI-powered solutions addressing real healthcare challenges, are accelerating innovation across the industry. Healthcare has already embraced tools like electronic health records and telehealth and continues to adopt solutions designed to improve patient outcomes while reducing costs. While new companies emerge with bold ideas and strong missions, success today requires a capable team that can integrate and scale within the complex realities of existing healthcare infrastructure.

We’re excited to further our mission to democratize healthcare access for overlooked populations by backing early-stage companies innovating for health equity. Our core belief is that equitable health solutions can produce long-term value and lower systemic healthcare costs.

To that end, we’re sharing several areas we’re actively tracking for innovation. Our investments won’t be limited to these categories; we also welcome ideas outside of them when a company’s mission aligns with our goal of optimizing health for all. Some areas reflect existing investments in our portfolio, often with one or more of the priority areas intersecting, while others are emerging opportunities we’re watching closely with the hope of finding a strong related investment.

Special thanks to Coyote Ventures team members for contributing to this content: Jessica Karr, Priyanka Vaidya, Erica Maissy, Mary DeFeo, and Nina Joshi. Art by Andrea Morin.

Human Health & Lifespan

Social & Structural Health

Whole-Person Health

Systems & Infrastructure

Science & Frontier Technology

 FAQs

FUNDRAISING?